Celgene profit beats as psoriasis drug sales surge

The drugmaker posted a net profit of $1.07 billion, or $1.50 per share, for the three months ended Dec. 31, compared with a loss of $81 million, or 10 cents per share, a year earlier,

from Earnings https://cnb.cx/2UtiPMD
via IFTTT